Free Trial
ASX:IDX

Integral Diagnostics (IDX) Stock Price, News & Analysis

Integral Diagnostics logo

About Integral Diagnostics Stock (ASX:IDX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
240,828 shs
Average Volume
N/A
Market Capitalization
$1.10 billion
P/E Ratio
N/A
Dividend Yield
1.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Receive IDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

IDX Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Positive Report for Integral Diagnostics Ltd. (IDX) from Citi
See More Headlines

IDX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Integral Diagnostics investors own include electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Credit Suisse Group (CS), Chimerix (CMRX), Capricor Therapeutics (CAPR) and Bathurst Resources (BRL).

Company Calendar

Ex-Dividend for 4/6 Dividend
3/05/2025
Record date for 4/6 Dividend
4/06/2025
Dividend Payable
4/06/2025
Today
5/31/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:IDX
CIK
N/A
Fax
N/A
Employees
2,010
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.39
Net Income
-$60.70 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$469.70 million
Price / Cash Flow
23.99
Book Value
A$1.29 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.10 billion
Optionable
Not Optionable
Beta
0.73
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (ASX:IDX) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners